Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
In committeeWhat this bill is intended to do
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Latest action
Jan 3, 2025Referred to the House Committee on Energy and Commerce.
No grade provided. The Quiet Ledger grades only on a bill's full statutory text, which Congress.gov hasn't published for this bill yet. PIN re-checks automatically and grades it the moment the text appears.